Back to top

Tale of the Tape

Zacks Equity Research

Achillion Pharmaceuticals (ACHN) Jumps Stock Up 20.9%
June 17, 2014


Trades from $3
Achillion Pharmaceuticals, Inc. (ACHN) was a big mover last session, as its shares rose almost 21% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the uptrend trend for the company, as the stock is now up nearly 193% in the past one-month timeframe.

In the last 30 days, the company witnessed one positive estimate revision and the Zacks Consensus Estimate also moved higher, suggesting solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s rally can turn into more strength down the road.

Achillion Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other better-ranked stocks in the medical sector include Gilead Sciences Inc. (GILD - Analyst Report) , ANI Pharmaceuticals, Inc. (ANIP - Snapshot Report) and Illumina Inc. (ILMN - Analyst Report) . All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>